Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, our focus is on Bioasis Technologies (BTI.V), a Canadian firm developing groundbreaking IP to help transport therapeutic drugs across the brain blood barrier.

Enjoy!

 

Written By:

Gaalen Engen

More By This Author
Tags:
Biotech
Featured Content
Health Science
Roundtable
Video
best canadian biotech company
bioasis technologies
blood brain barrier
BTI.V
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments